310 related articles for article (PubMed ID: 23428088)
1. Reductions in human Lyme disease risk due to the effects of oral vaccination on tick-to-mouse and mouse-to-tick transmission.
Voordouw MJ; Tupper H; Önder Ö; Devevey G; Graves CJ; Kemps BD; Brisson D
Vector Borne Zoonotic Dis; 2013 Apr; 13(4):203-14. PubMed ID: 23428088
[TBL] [Abstract][Full Text] [Related]
2. OspA immunization decreases transmission of Borrelia burgdorferi spirochetes from infected Peromyscus leucopus mice to larval Ixodes scapularis ticks.
Tsao J; Barbour AG; Luke CJ; Fikrig E; Fish D
Vector Borne Zoonotic Dis; 2001; 1(1):65-74. PubMed ID: 12653137
[TBL] [Abstract][Full Text] [Related]
3. Protective efficacy of an oral vaccine to reduce carriage of Borrelia burgdorferi (strain N40) in mouse and tick reservoirs.
Scheckelhoff MR; Telford SR; Hu LT
Vaccine; 2006 Mar; 24(11):1949-57. PubMed ID: 16300863
[TBL] [Abstract][Full Text] [Related]
4. Reservoir targeted vaccine against Borrelia burgdorferi: a new strategy to prevent Lyme disease transmission.
Richer LM; Brisson D; Melo R; Ostfeld RS; Zeidner N; Gomes-Solecki M
J Infect Dis; 2014 Jun; 209(12):1972-80. PubMed ID: 24523510
[TBL] [Abstract][Full Text] [Related]
5. Reservoir targeted vaccine for lyme borreliosis induces a yearlong, neutralizing antibody response to OspA in white-footed mice.
Meirelles Richer L; Aroso M; Contente-Cuomo T; Ivanova L; Gomes-Solecki M
Clin Vaccine Immunol; 2011 Nov; 18(11):1809-16. PubMed ID: 21918116
[TBL] [Abstract][Full Text] [Related]
6. Predicted outcomes of vaccinating wildlife to reduce human risk of Lyme disease.
Tsao K; Fish D; Galvani AP
Vector Borne Zoonotic Dis; 2012 Jul; 12(7):544-51. PubMed ID: 22251312
[TBL] [Abstract][Full Text] [Related]
7. Development of a baited oral vaccine for use in reservoir-targeted strategies against Lyme disease.
Bhattacharya D; Bensaci M; Luker KE; Luker G; Wisdom S; Telford SR; Hu LT
Vaccine; 2011 Oct; 29(44):7818-25. PubMed ID: 21816190
[TBL] [Abstract][Full Text] [Related]
8. Immunization with a recombinant subunit OspA vaccine markedly impacts the rate of newly acquired Borrelia burgdorferi infections in client-owned dogs living in a coastal community in Maine, USA.
Eschner AK; Mugnai K
Parasit Vectors; 2015 Feb; 8():92. PubMed ID: 25890386
[TBL] [Abstract][Full Text] [Related]
9. Blocking pathogen transmission at the source: reservoir targeted OspA-based vaccines against Borrelia burgdorferi.
Gomes-Solecki M
Front Cell Infect Microbiol; 2014; 4():136. PubMed ID: 25309883
[TBL] [Abstract][Full Text] [Related]
10. Identification of a defined linear epitope in the OspA protein of the Lyme disease spirochetes that elicits bactericidal antibody responses: Implications for vaccine development.
Izac JR; Oliver LD; Earnhart CG; Marconi RT
Vaccine; 2017 May; 35(24):3178-3185. PubMed ID: 28479174
[TBL] [Abstract][Full Text] [Related]
11. Outer surface protein A protects Lyme disease spirochetes from acquired host immunity in the tick vector.
Battisti JM; Bono JL; Rosa PA; Schrumpf ME; Schwan TG; Policastro PF
Infect Immun; 2008 Nov; 76(11):5228-37. PubMed ID: 18779341
[TBL] [Abstract][Full Text] [Related]
12. Vaccination against Lyme disease: past, present, and future.
Embers ME; Narasimhan S
Front Cell Infect Microbiol; 2013; 3():6. PubMed ID: 23407755
[TBL] [Abstract][Full Text] [Related]
13. Demonstration of the ability of a canine Lyme vaccine to reduce the incidence of histological synovial lesions following experimentally-induced canine Lyme borreliosis.
Grosenbaugh DA; Rissi DR; Krimer PM
Vet Immunol Immunopathol; 2016 Nov; 180():29-33. PubMed ID: 27692092
[TBL] [Abstract][Full Text] [Related]
14. Borrelia burgdorferi OspA is an arthropod-specific transmission-blocking Lyme disease vaccine.
de Silva AM; Telford SR; Brunet LR; Barthold SW; Fikrig E
J Exp Med; 1996 Jan; 183(1):271-5. PubMed ID: 8551231
[TBL] [Abstract][Full Text] [Related]
15. Production of outer surface protein A by Borrelia burgdorferi during transmission from infected mammals to feeding ticks is insufficient to trigger OspA seroconversion.
Woodman ME; Cooley AE; Stevenson B
FEMS Immunol Med Microbiol; 2008 Nov; 54(2):277-82. PubMed ID: 18793197
[TBL] [Abstract][Full Text] [Related]
16. Influence of outer surface protein A antibody on Borrelia burgdorferi within feeding ticks.
de Silva AM; Zeidner NS; Zhang Y; Dolan MC; Piesman J; Fikrig E
Infect Immun; 1999 Jan; 67(1):30-5. PubMed ID: 9864192
[TBL] [Abstract][Full Text] [Related]
17. Vaccination of natural reservoir hosts with recombinant lipidated OspA induces a transmission-blocking immunity against Lyme disease spirochaetes associated with high levels of LA-2 equivalent antibodies.
Kurtenbach K; Dizij A; Voet P; Hauser P; Simon MM
Vaccine; 1997 Oct; 15(15):1670-4. PubMed ID: 9364698
[TBL] [Abstract][Full Text] [Related]
18. A reverse transcriptase-polymerase chain reaction assay of Borrelia burgdorferi 16S rRNA for highly sensitive quantification of pathogen load in a vector.
Ornstein K; Barbour AG
Vector Borne Zoonotic Dis; 2006; 6(1):103-12. PubMed ID: 16584333
[TBL] [Abstract][Full Text] [Related]
19. The growing global battle against blood-sucking ticks.
Moyer MW
Nature; 2015 Aug; 524(7566):406-8. PubMed ID: 26310749
[No Abstract] [Full Text] [Related]
20. Differential immune responses to Borrelia burgdorferi in European wild rodent species influence spirochete transmission to Ixodes ricinus L. (Acari: Ixodidae).
Kurtenbach K; Dizij A; Seitz HM; Margos G; Moter SE; Kramer MD; Wallich R; Schaible UE; Simon MM
Infect Immun; 1994 Dec; 62(12):5344-52. PubMed ID: 7960113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
